These success, together with a prior report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the notion of targeting ACKR3 as a novel strategy to modulate the opioid method, which could open new therapeutic avenues for opioid-linked disorders. A investigation research posted in Anesthesiology https://pikn469rha7.blog-eye.com/profile